Human Kallikrein 14: A New Potential Biomarker for Ovarian and Breast Cancer

Cancer Research

Volumn 63, Issue 24, 2003, Pages 9032-9041

  Borgoño, Carla A ^a,b   Grass, Linda ^a   Soosaipillai, Antoninus ^a   Yousef, George M ^a,b   Petraki, Constantina D ^c   Howarth, David H C ^a   Fracchioli, Stefano ^d   Katsaros, Dionyssios ^d   Diamandis, Eleftherios P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c EVANGELISMOS HOSPITAL   (Greece)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; KALLIKREIN; KALLIKREIN 14; POLYCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; REAGENT; RECOMBINANT PROTEIN; SERINE PROTEINASE; TUMOR MARKER; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODY PRODUCTION; ARTICLE; BIOSYNTHESIS; BLOOD; BODY FLUID; BREAST CANCER; BREAST TUMOR; CANCER TISSUE; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; ENDOCRINE TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; GENE; GENE EXPRESSION; GENETICS; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KALLIKREIN GENE 14; METABOLISM; MOLECULAR GENETICS; MOUSE; MOUSE STRAIN; NEOPLASM; NONHUMAN; OVARY CANCER; OVARY TUMOR; PICHIA PASTORIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN LOCALIZATION; SENSITIVITY AND SPECIFICITY; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; BREAST NEOPLASMS; CELL LINE, TUMOR; CYTOSOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KALLIKREINS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASMS, HORMONE-DEPENDENT; OVARIAN NEOPLASMS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0347951241     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Diamandis, E. P., Yousef, G. M., Luo, L. Y., Magklara, A., and Obiezu, C. V. The new human kallikrein gene family: implications in carcinogenesis. Trends Endocrinol. Metab., 11: 54-60, 2000.
2. Yousef, G. M., and Diamandis, E. P. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev., 22: 184-204, 2001.
3. Diamandis, E. P., Yousef, G. M., Clements, J., Ashworth, L. K., Yoshida, S., Egelrud, T., Nelson, P. S., Shiosaka, S., Little, S., Lilja, H., Stenman, U. H., Rittenhouse, H. G., and Wain, H. New nomenclature for the human tissue kallikrein gene family. Clin. Chem., 46: 1855-1858, 2000.
4. Diarnandis, E. P., and Yousef, G. M. Human tissue kallikrein gene family: a rich source of novel disease biomarkers. Exp. Rev. Mol. Diagn., 1: 182-190, 2001.
5. Diamandis, E. P., and Yousef, G. M. Human tissue kallikreins: a family of new cancer biomarkers. Clin. Chem., 48: 1198-1205, 2002.
6. Diarnandis, E. P. Prostate-specific antigen-its usefulness in clinical medicine. Trends Endocrinol. Metab., 9: 310-316, 1998.
7. Magklara, A., Scorilas, A., Catalona. W. J., and Diamandis, E. P. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA. Clin. Chem., 45: 1960-1966, 1999.
8. Yousef, G. M., Polymeris, M. E., Grass, L., Soosaipillai, A., Chan, P. C., Scorilas, A., Borgono, C., Harbeck, N., Schmalfeldt, B., Dorn, J., Schmitt, M., and Diamandis, E. P. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. Cancer Res., 63: 3958-3965, 2003.
9. Diamandis, E. P., Scorilas, A., Fracchioli, S., Van Gramberen, M., De Bruijn, H., Henrik, A., Soosaipillai, A., Grass, L., Yousef, G. M., Stenman, U. H., Massobrio, M., Van Der Zee, A. G., Vergote, I., and Katsaros, D. Human kallikrein 6 (hK6): A new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J. Clin. Oncol., 21: 1035-1043, 2003.
10. Kishi, T., Grass, L., Soosaipillai, A., Scorilas, A., Harbeck, N., Schmalfeldt, B., Dorn, J., Mysliwiec, M., Schmitt, M., and Diamandis, E. P. Human kallikrein 8, a novel biomarker for ovarian carcinoma. Cancer Res., 63: 2771-2774, 2003.
11. Luo, L. Y., Katsaros, D., Scorilas, A., Fracchioli, S., Bellino, R., van Gramberen, M., de Bruijn, H., Henrik, A., Stenman, U. H., Massobrio, M., van der Zee, A. G., Vergote, I., and Diamandis, E. P. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. Cancer Res., 63: 807-811, 2003.
12. Diamandis, E. P., Okui, A., Mitsui, S., Luo, L. Y., Soosaipillai, A., Grass, L., Nakamura, T., Howarth, D. J., and Yamaguchi, N. Human kallikrein II: A new biomarker of prostate and ovarian carcinoma. Cancer Res., 62: 295-300, 2002.
13. Yousef, G. M., and Diamandis, E. P. Kallikreins, steroid hormones and ovarian cancer: is there a link? Minerva. Endocrinol., 27: 157-166, 2002.
14. Yousef, G. M., Magklara, A., Chang, A., Jung, K., Katsaros, D., and Diamandis, E. P. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. Cancer Res., 61: 3425-3431, 2001.
15. Hooper, J. D., Bui, L. T., Rae, F. K., Harvey, T. J., Myers, S. A., Ashworth, L. K., and Clements, J. A. Identification and characterization of klk14, a novel kallikrein serine protease gene located on human chromosome 19q13.4 and expressed in prostate and skeletal muscle. Genomics, 73: 117-122, 2001.
16. Yousef, G. M., Fracchioli, S., Scorilas, A., Borgono, C. A., Iskander, L., Puopolo, M., Massobrio, M., Diamandis, E. P., and Katsaros, D. Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer. Am. J. Clin. Pathol., 119: 346-355, 2003.
17. Yousef, G. M., Stephan, C., Scorilas, A., Abd Ellatif, M., Jung, K., Kristiansen, G. O., Jung, M., Polymeris, M. E., and Diamandis, E. P. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues. Prostate, 56: 287-292, 2003.
18. Yousef, G. M., Borgono, C. A., Scorilas, A., Ponzone, R., Biglia, N., Iskander, L., Polymeris, M. E., Roagna, R., Sismondi, P., and Diamandis, E. P. Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis. Br. J. Cancer, 87: 1287-1293, 2002.
19. Luo, L. Y., Grass, L., Howarth, D. J., Thibault, P., Ong, H., and Diamandis, E. P. Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues. Clin. Chem., 47: 237-246, 2001.
20. Christopoulos, T. K., and Diamandis, E. P. Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates. Anal. Chem., 64: 342-346, 1992.
21. Hassapoglidou, S., Diamandis, E. P., and Sutherland, D. J. Quanfification of p53 protein in tumor cell lines, breast tissue extracts and serum with time-resolved immunofluorometry. Oncogene, 8: 1501-1509, 1993.
22. Petraki, C. D., Karavana, V. N., Skoufogiannis, P. T., Little, S. P., Howarth, D. J., Yousef, G. M., and Diamandis, E. P. The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry. J. Histochem. Cytochem., 49: 1431-1441, 2001.
23. Petraki, C. D., Karavana, V. N., Luo, L. Y., and Diamandis, E. P. Human kallikrein 10 expression in normal tissues by immunohistochemistry. J. Histochem. Cytochem., 50: 1247-1261, 2002.
24. Petraki, C. D., Karavana, V. N., and Diamandis, E. P. Human kallikrein 13 expression in normal tissues: an immunohistochemical study. J. Histochem. Cytochem., 51: 493-501, 2003.
25. Lu, H. S., Lin, F. K., Chao, L., and Chao, J. Human urinary kallikrein. Complete amino acid sequence and sites of glycosylation. Int. J. Pept. Protein Res., 33: 237-249, 1989.
26. Mikolajczyk, S. D., Millar, L. S., Marker, K. M., Grauer, L. S., Goel, A., Cass, M. M., Kumar, A., and Saedi, M. S. Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2. Eur. J. Biochem., 246: 440-446, 1997.
27. Eerola, R., Piironen, T., Pettersson, K., Lovgren, J., Vehniainen, M., Lilja, H., Dowell, B., Lovgren, T., and Karp, M. Immunoreactivity of recombinant human glandular kallikrein using monoclonal antibodies raised against prostate-specific antigen. Prostate, 31: 84-90, 1997.
28. Belanger, A., van Halbeek, H., Graves, H. C., Grandbois, K., Stamey, T. A., Huang, L., Poppe, I., and Labrie, F. Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. Prostate, 27: 187-197, 1995.
29. Campbell, A. M. Production and Purification of Antibodies. In: E. P. Diamandis and T. K. Christopoulos (eds.), Immunoassay, pp. 95-115. San Diego: Academic Press, 1996.
30. Obiezu, C. V., Soosaipillai, A., Jung, K., Stephan, C., Scorilas, A., Howarth, D. H., and Diamandis, E. P. Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry. Clin. Chem., 48: 1232-1240, 2002.
31. Diamandis, E. P., Yousef, G. M., Soosaipillai, A. R., Grass, L., Porter, A., Little, S., and Sotiropoulou, G. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. Clin. Biochem., 33: 369-375, 2000.
32. Kishi, T., Grass, L., Soosaipillai, A., Shimizu-Okabe, C., and Diamandis, E. P. Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids. Clin. Chem., 49: 87-96, 2003.
33. Kapadia, C., Chang, A., Sotiropoulou, G., Yousef, G. M., Grass, L., Soosaipillai, A., Xing, X., Howarth, D. H., and Diamandis, E. P. Human kallikrein 13: production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay. Clin. Chem., 49: 77-86, 2003.
34. Chan, D. W., and Schwartz, M. K. Tumor Markers: Introduction and General Principles. In: E. P. Diamandis, H. A. Fritsch, H. Lilja, D. W. Chan, and M. H. Schwartz (eds.), Tumor Markers: Physiology, Pathobiology, Technology, and Clinical Applications, pp. 9-18. Washington, DC: AACC Press, 2002.
35. Duffy, M. G. The role of proteolytic enzymes in cancer invasion and metastasis. Clin. Exp. Metastasis, 10: 145-155, 1991.
36. Noel, A., Gilles, C., Bajou, K., Devy, L., Kebers, F., Lewalle, J. M., Maquoi, E., Munaut, C., Remacle, A., and Foidart, J. M. Emerging roles for proteinases in cancer. Invasion Metastasis, 17: 221-239, 1997.
37. Yu, H., and Diamandis, E. P. Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies. Clin. Chem., 39: 2108-2114, 1993.
38. Zhang, W. M., Finne, P., Leinonen, J., Vesalainen, S., Nordling, S., Rannikko, S., and Stenman, U. H. Characterization and immunological determination of the complex between prostate-specific antigen and α2-macroglobulin. Clin. Chem., 44: 2471-2479, 1998.
39. Christensson, A., Laurell, C. B., and Lilja, H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur. J. Biochem., 194: 755-763, 1990.
40. Stenman, U. H., Leinonen, J., Alfthan, H., Rannikko, S., Tuhkanen, K., and Alfthan, O. A complex between prostate-specific antigen and α 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res., 51: 222-226, 1991.
41. Lilja, H., Christensson, A., Dahlen, U., Matikainen, M. T., Nilsson, O., Pettersson, K., and Lovgren, T. Prostate-specific antigen in serum occurs predominantly in complex with α 1-antichymotrypsin. Clin. Chem., 37: 1618-1625, 1991.
42. Ferguson, R. A., Yu, H., Kalyvas, M., Zammit, S., and Diamandis, E. P. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Clin. Chem., 42: 675-684, 1996.
43. Stephan, C., Jung, K., Lein, M., Sinha, P., Schnorr, D., and Loening, S. A. Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer. Cancer Epidemiol. Biomark. Prev., 9: 1133-1147, 2000.
44. Saedi, M. S., Zhu, Z., Marker, K., Liu, R. S., Carpenter, P. M., Rittenhouse, H., and Mikolajczyk, S. D. Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells. Int. J. Cancer, 94: 558-563, 2001.
45. Cao, Y., Lundwall, A., Gadaleanu, V., Lilja, H., and Bjartell, A. Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2. Am. J. Pathol., 161. 2053-2063, 2002.
46. Hutchinson, S., Luo, L. Y., Yousef, G. M., Soosaipillai, A., and Diamandis, E. P. Purification of human kallikrein 6 from biological fluids and identification of its complex with β(1)-antichymotrypsin. Clin. Chem., 49: 746-751, 2003.
47. Rittenhouse, H. G., Finlay, J. A., Mikolajczyk, S. D., and Partin, A. W. Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit. Rev. Clin. Lab. Sci., 35: 275-368, 1998.
48. Henttu, P., and Vihko, P. Prostate-specific antigen and human glandular kallikrein: two kallikreins of the human prostate. Ann. Med., 26: 157-164, 1994.
49. Tanimoto, H., Underwood, L. J., Shigemasa, K., Yan Yan, M. S., Clarke, J., Parmley, T. H., and O'Brien, T. J, The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells. Cancer (Phila.), 86: 2074-2082, 1999.
50. Yousef, G. M., Kyriakopoulou, L. G., Scorilas, A., Fracchioli, S., Ghiringhello, B., Zarghooni, M., Chang, A., Diamandis, M., Giardina, G., Hartwick, W. J., Richiardi, G., Massobrio, M., Diamandis, E. P., and Katsaros, D. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: A new independent and favorable prognostic marker. Cancer Res., 61: 7811-7818, 2001.
51. Hoffman, B. R., Katsaros, D., Scorilas, A., Diamandis, P., Fracchioli, S., Rigault de la Longrais, I. A., Colgan, T., Puopolo, M., Giardina, G., Massobrio, M., and Diamandis, E. P. Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker. Br. J. Cancer, 87: 763-771, 2002.
52. Foekens, J. A., Diamandis, E. P., Yu, H., Look, M. P., Meijer-van Gelder, M. E., van Putten, W. L., and Klijn, J. G. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer. Br. J. Cancer, 79: 888-894, 1999.
53. Luo, L. Y., Diamandis, E. P., Look, M. P., Soosaipillai, A. P., and Foekens, J. A. Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance. Br. J. Cancer, 86: 1790-1796, 2002.